Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Clinical trial NCT06233058 · UNKNOWN

Trial details

NCT number: NCT06233058
Sponsor: Bio-innova Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-03-05
Primary completion: 2024-04-29
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.